What problem does this paper attempt to address?

Based on the provided abstract and research content, the problems that this paper attempts to solve can be summarized as follows: 1. **Develop new anti - cancer metal complexes**: The paper designed and synthesized two new copper(II) and iron(III) complexes, namely \[CuL_2Cl\]Cl·H_2O (1) and \[FeL_2Cl_2\]Cl·MeOH·CHCl_3·H_2O (2), where L is (Z)-N'-((E)-3 - methyl - 4 - oxothiazolidin - 2 - ylidene)pyridinecarbohydrazide. These complexes were designed to explore their interactions with DNA and serum albumin, as well as their potential anti - cancer activities. 2. **Study the structural characteristics of the complexes**: The crystal structures of these two complexes were determined by X - ray diffraction technique, and it was found that they both belong to the triclinic P - 1 space group. Specifically, complex 1 consists of a positively charged main unit, a negative chloride ion and some solvent molecules; complex 2 also has a similar structure, but the central iron atom forms a distorted octahedral geometry. 3. **Evaluate the DNA - binding ability of the complexes**: The binding modes of these two complexes with DNA were studied by fluorescence and electronic absorption spectroscopy. The results showed that both complexes 1 and 2 can bind to DNA in a moderately strong intercalation mode, with binding constants \(K_{app}\) of \(2.40\times10^5\) M\(^{-1}\) and \(6.49\times10^5\) M\(^{-1}\), respectively. In addition, gel electrophoresis experiments showed that both complexes exhibit obvious DNA - cleavage activities under the oxidative damage pathway, and the cleavage activity of complex 1 is stronger than that of complex 2. 4. **Investigate the interactions between the complexes and bovine serum albumin (BSA)**: The binding of these two complexes to BSA was studied, and it was found that they can both bind to BSA efficiently and quench the fluorescence of BSA through a static mechanism. Thermodynamic parameter analysis showed that hydrophobic interactions play a key role in the binding process. 5. **Explore the cytotoxicity and targeting of the complexes**: Cytotoxicity tests showed that complex 1 has stronger anti - cancer activity than complex 2. Further research showed that complex 1 has specific lysosomal targeting behavior, and its accumulation in lysosomes was observed under confocal laser scanning microscopy (CLSM), which led to the destruction of lysosomal integrity. In summary, this paper mainly solves how to design and synthesize new copper(II) and iron(III) complexes, and the specific performances and potential mechanisms of these complexes in terms of DNA binding, BSA interaction, DNA - cleavage activity, cytotoxicity and lysosomal targeting. These studies are helpful for the development of more effective anti - cancer drugs.

Synthesis, crystal structures, anticancer activities and molecular docking studies of novel thiazolidinone Cu( ii ) and Fe( iii ) complexes targeting lysosomes: special emphasis on their binding to DNA/BSA

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand

Synthesis, Characterization, DNA Binding and Cleavage, BSA Interaction and Anticancer Activity of Dinuclear Zinc Complexes.

Synthesis, Characterization, and Biological Activities of Two Cu(II) and Zn(II) Complexes with One Polyquinoline Ligand.

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Manipulating Fe(II) spin states to achieve higher anti-tumor cell activities in multinuclear complexes

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands

A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity

Synthesis and DNA Interactions Study of Novel Fluorinated Pyridinium Platinum (IV) Complexes with Tumor Targeting Activity

Synthesis, crystal structures and anticancer studies of Ni (II), Co (III) and Zn (II) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

Syntheses, crystal structures of copper (II)-based complexes of sulfonamide derivatives and their anticancer effects through the synergistic effect of anti-angiogenesis, anti-inflammation, pro-apoptosis and cuproptosis

Synthesis and Structure Elucidation of Two Essential Metal Complexes: In-Vitro Studies of Their BSA/HSA-Binding Properties, Docking Simulations, and Anticancer Activities

The X-ray crystal structures, molecular docking and biological activities of two novel Cu(II) and Zn(II) complexes with a ligand having a potentially N4O2 donor set and two nitro phenyl rings as pendant arms

Bifunctional tetrazole–carboxylate ligand based Zn(II) complexes: synthesis and their excellent potential anticancer properties

Synthesis and Crystal Structure of New Monometallic Ni(II) and Co(II) Complexes with an Asymmetrical Aroylhydrazone: Effects of the Complexes on DNA/protein Binding Property, Molecular Docking, and in Vitro Anticancer Activity

Synthesis, DNA binding and anticancer properties of new Cu(II) and Zn(II) complexes of a Schiff base ligand containing a triphenylphosphonium as a lipophilic cation

Novel tetranuclear grid-like Zn(II) complexes derived from dihydrazone pyrimidine derivatives as antitumor agents